| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |